Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$8.02 - $8.67 $6,528 - $7,057
814 Added 39.55%
2,872 $24.4 Million
Q4 2023

Feb 09, 2024

BUY
$7.78 - $8.62 $1,626 - $1,801
209 Added 11.3%
2,058 $16.9 Million
Q3 2023

Nov 09, 2023

SELL
$7.85 - $8.94 $6,782 - $7,724
-864 Reduced 31.85%
1,849 $15.4 Million
Q2 2023

Aug 02, 2023

BUY
$8.04 - $9.0 $21,812 - $24,417
2,713 New
2,713 $22.7 Million

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $43.4B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Nemes Rush Group LLC Portfolio

Follow Nemes Rush Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nemes Rush Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nemes Rush Group LLC with notifications on news.